Details of the Drug

General Information of Drug (ID: DM948AP)

Drug Name

MAb114

Indication

Disease Entry	ICD 11	Status	REF
Ebola virus infection	1D60.0	Phase 2/3	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ebola virus Envelope glycoprotein (EV GP)	TT2F0AU	VGP_EBOZM	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03719586) Investigational Therapeutics for the Treatment of People With Ebola Virus Disease. U.S. National Institutes of Health.
2	Ansuvimab: First Approval. Drugs. 2021 Apr;81(5):595-598.